Showing results (241-250 of 3,469) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|May 25, 2006
Possible interethnic differences in omeprazole pharmacokinetics : comparison of Jordanian Arabs with other populationsSireen Shilbayeh, Maha F TutunjiClinical Pharmacokinetics|May 25, 2006
Predicting the toxicity of weekly docetaxel in advanced cancerKellie A Charles, Laurent P Rivory, Martin R Stockler, et al.Clinical Pharmacokinetics|October 1, 1991
Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II)D J Greenblatt, J S Harmatz, R I ShaderClinical Pharmacokinetics|September 1, 1991
Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I)D J Greenblatt, J S Harmatz, R I ShaderClinical Pharmacokinetics|March 3, 2006
Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children : validation of liquid chromatography tandem mass spectrometry methodManfred Rauh, Daniel Stachel, Michaela Kuhlen, et al.Clinical Pharmacokinetics|June 26, 2004
Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokineticsBrian P Kearney, John F Flaherty, Jaymin ShahClinical Pharmacokinetics|December 1, 2004
Biowaivers for oral immediate-release products: implications of linear pharmacokineticsFried Faassen, Herman VromansClinical Pharmacokinetics|December 1, 2004
Magnitude and time-course of arterio-venous differences in blood-alcohol concentration in healthy menAlan Wayne Jones, Lars Lindberg, Sven-Gunnar OlssonClinical Pharmacokinetics|June 4, 2005
Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosisSerge C L M Cremers, Goonaseelan Pillai, Socrates E PapapoulosClinical Pharmacokinetics|May 6, 2005
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipientsHugh Wiltshire, Sarapee Hirankarn, Colm Farrell, et al.Pageof 347